Eco R1 Capital, LLC Beam Therapeutics Inc. Transaction History
Eco R1 Capital, LLC
- $2.31 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
242Shares Held
76.7MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$218 Million1.01% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$203 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$188 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$128 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.87B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...